Loading…
Rapid Micro Biosystems, Inc. is projected to rise to $1.98 by 2027, a +1% move from its current price of $1.96. RPID is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.89 | $1.96 | $2.03 | 0.00% |
| May 30 | $1.86 | $1.96 | $2.06 | +0.01% |
| May 31 | $1.84 | $1.96 | $2.09 | +0.01% |
| Jun 1 | $1.82 | $1.96 | $2.11 | +0.01% |
| Jun 2 | $1.81 | $1.96 | $2.13 | +0.02% |
| Jun 3 | $1.79 | $1.96 | $2.14 | +0.02% |
| Jun 4 | $1.78 | $1.96 | $2.16 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.78 | $1.96 | $2.16 | +0.02% |
| Week 2 | $1.71 | $1.96 | $2.25 | +0.05% |
| Week 3 | $1.66 | $1.96 | $2.32 | +0.07% |
| Week 4 | $1.62 | $1.96 | $2.38 | +0.10% |
| Week 5 | $1.58 | $1.96 | $2.44 | +0.12% |
| Week 6 | $1.55 | $1.96 | $2.49 | +0.15% |
| Week 7 | $1.52 | $1.96 | $2.54 | +0.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rapid Micro Biosystems, Inc. is a healthcare company focused on life sciences technology that provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. Its Growth Direct platform includes the Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
The company’s solutions automate and modernize the manual microbial quality control testing workflows for therapeutic modalities such as biologics and cell and gene therapies, vaccines, and sterile injectables, and it also offers onsite technical training services.
Its offerings span environmental monitoring, water, bioburden, and sterility release testing applications. Rapid Micro Biosystems also markets RMBNucleus Mold Alarm software and Growth Direct LIMS connection software. The company was formerly known as Genomic Profiling Systems, Inc., renamed to Rapid Micro Biosystems, Inc., and was incorporated in 2006.
It is headquartered in Lexington, Massachusetts.
Rapid Micro Biosystems, Inc. (RPID) trades at $2.05 per share and has a market capitalization of $102.13M, with a rank of 4228 among stocks by market cap.
Near term, the 2026 forecast shows a neutral outlook with an average price of $2.05 and a range from $1.96 to $2.61 (ROI 0, sentiment NEUTRAL).
Beyond 2026, the forecast turns bullish, with the 2030 average projected at $3.45 and a max of $5.44 (ROI 68.1%, sentiment BULLISH). Looking further, the 2040 forecast shows an average of $6.83 with a max of $13.02 (ROI 233.1%, sentiment BULLISH), and the 2050 forecast points to an average of $15.09 with a max of $32.13 (ROI 636.2%, sentiment BULLISH).
A major floor 23.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.3% away) — a key level to hold.
The nearest ceiling, 34.2% above — a clean break opens room to run.
A major ceiling 138.8% above — clearing it would confirm fresh momentum.
Key RPID support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RPID market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.02 | Sell | $2.02 | Sell |
| MA 10 | $2.09 | Sell | $2.10 | Sell |
| MA 20 | $2.30 | Sell | $2.21 | Sell |
| MA 50 | $2.31 | Sell | $2.49 | Sell |
| MA 100 | $3.12 | Sell | $2.82 | Sell |
| MA 200 | $3.19 | Sell | $2.97 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.33 | Neutral |
| Stoch RSI (14) | 9.97 | Buy |
| CCI (20) | -98.81 | Neutral |
| Williams %R (14) | -99.26 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -25.48 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.74 | Buy |
| TRIX (15) | -0.49 | Sell |
| Awesome (5,34) | -0.26 | Sell |
| Ultimate (7,14,28) | 31.61 | Neutral |
| Momentum (10) | -0.62 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 2.00 | Sell |
| ADX (14) | 20.79 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day picture looks bearish on the current tape. RSI14 is 40, indicating subdued momentum, with the 50-day simple moving average at $2.34 and the 200-day simple moving average at $3.20.
Support is reported at $1.96 and resistance at $2.63, with a 30-day price range spanning $1.59 to $2.64. These levels help frame near-term risk and potential bounce zones for traders watching the stock.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.96 | $1.96 | $2.47 | 0% | Neutral | |
| $1.52 | $1.98 | $2.76 | +1% | Neutral | |
| $1.63 | $2.21 | $3.23 | +13% | Neutral | |
| $2.03 | $2.83 | $4.29 | +45% | Bullish | |
| $2.08 | $2.99 | $4.67 | +53% | Bullish | |
| $2.20 | $3.25 | $5.20 | +66% | Bullish | |
| $2.26 | $3.42 | $5.62 | +75% | Bullish | |
| $1.93 | $2.99 | $5.01 | +52% | Bullish | |
| $2.12 | $3.37 | $5.75 | +72% | Bullish | |
| $2.54 | $4.11 | $7.15 | +110% | Bullish | |
| $3.07 | $5.50 | $10.30 | +180% | Bullish | |
| $5.47 | $11.77 | $24.55 | +500% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.96 | $1.96 | $2.30 | +0.00% |
| June 2026 | $1.62 | $1.92 | $2.33 | -2.21% |
| July 2026 | $1.64 | $1.97 | $2.44 | +2.59% |
| August 2026 | $1.65 | $1.99 | $2.50 | +1.24% |
| September 2026 | $1.56 | $1.89 | $2.40 | -4.85% |
| October 2026 | $1.51 | $1.84 | $2.36 | -2.65% |
| November 2026 | $1.54 | $1.90 | $2.46 | +3.16% |
| December 2026 | $1.53 | $1.89 | $2.47 | -0.44% |
Click any year to see its month-by-month RPID forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RPID to range from $1.96 to $2.47 through 2026. The $1.96 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RPID price prediction for 2027 points to an average of $1.98 (low $1.52, high $2.76) — a potential gain of +1% on today's $1.96. A consolidation phase looks the most probable path here.
In 2028, RPID is projected to trade between $1.63 and $3.23, averaging $2.21 — a potential gain of +13% from today's $1.96. That is up +12% on the projected 2027 average. Price action looks broadly range-bound.
Rapid Micro Biosystems, Inc.'s 2029 outlook centres on $2.83, within a $2.03 to $4.29 range. That is up +28% on the projected 2028 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RPID could reach as high as $4.67, with a base case around $2.99 and support toward $2.08 — roughly +53% from $1.96. Momentum favours further upside here.
Expect RPID to range from $2.20 to $5.20 through 2031. The $3.25 average target implies a +66% move from current prices. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RPID price prediction for 2032 points to an average of $3.42 (low $2.26, high $5.62) — a potential gain of +75% on today's $1.96. Momentum favours further upside here.
In 2033, RPID is projected to trade between $1.93 and $5.01, averaging $2.99 — a potential gain of +52% from today's $1.96. That is -13% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Rapid Micro Biosystems, Inc.'s 2034 outlook centres on $3.37, within a $2.12 to $5.75 range. That is up +13% on the projected 2033 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2035, RPID could reach as high as $7.15, with a base case around $4.11 and support toward $2.54 — roughly +110% from $1.96. Buyers look set to stay in control over this stretch.
Expect RPID to range from $3.07 to $10.30 through 2040. The $5.50 average target implies a +180% move from current prices. That is up +34% on the projected 2035 average. Momentum favours further upside here.
The RPID price prediction for 2050 points to an average of $11.77 (low $5.47, high $24.55) — a potential gain of +500% on today's $1.96. Buyers look set to stay in control over this stretch.
Investing $1,000 in RPID today (≈ 510.204082 RPID) could be worth
$6,003.27
+$5,003.27 (+500%) by 2050 · US Dollar
Based on the average projected RPID price of $11.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RPIDwould be worth at today's price.
$1,000 invested in RPID on May 27, 2025 (≈ 281.690145 RPID) would be worth
$552.11
-$447.89 (-44.8%) today · 0.55× · US Dollar
Based on a RPID entry price of $3.55 vs. today's $1.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.01 | $975.12 | -2.5% |
| 1 month ago | $2.36 | $830.51 | -16.9% |
| 3 months ago | $4.47 | $438.48 | -56.2% |
| 6 months ago | $4.19 | $467.78 | -53.2% |
| 1 year ago | $3.55 | $552.11 | -44.8% |
| All time (4.9y) ago | $21.4 | $91.59 | -90.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RPID forecast.
Our base-case forecast reaches $3.90 around 2035.
Implied market cap at $3.90: $176.76M
Multi-year forecasts indicate a bullish trajectory after 2026, with steadily higher average prices and meaningful ROI growth. By 2030 the average price is expected to be $3.45, with a max of $5.44 and an ROI of 68.1% in a bullish context. The longer horizon projects continued upside, with 2040 averaging $6.83 (max $13.02) and an ROI of 233.1%, and 2050 showing an average of $15.09 (max $32.13) and an ROI of 636.2% under bullish sentiment.
These projections imply substantial upside potential over time while noting that 2026 and 2027 are neutral and the near-term picture is bearish. The figures are estimates and not guarantees of future performance, and actual results may differ.
Tap a question to reveal the answer.
In 2030, the forecast lists a min of $2.37, an average of $3.45, and a max of $5.44, with an ROI of 68.1% and bullish sentiment.
The forecast shows neutral sentiment in 2026 and 2027, followed by bullish sentiment from 2028 onward, with rising average prices and ROI leading to substantial upside by 2030, 2040, and 2050.
Yes. The 2030 max is $5.44, and the 2033 max is $5.94, with higher highs projected in later years (2040 max $13.02 and 2050 max $32.13).
The stock shows bearish sentiment with RSI 14 at 40. The 50-day SMA is $2.34, the 200-day SMA is $3.20, with support at $1.96 and resistance at $2.63; the 30-day range is $1.59–$2.64.
Current price is $2.05 and market cap is $102.13M.
Rapid Micro Biosystems, Inc. Community Discussion
0Share your Rapid Micro Biosystems, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.